Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Coenzyme Q versus hypertension: does CoQ decrease endothelial superoxide generation?

M F McCarty1

  • 1Nutrition 21, San Diego, CA 92109, USA.

Medical Hypotheses
|December 23, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Calcium supplementation, renin, and vascular risk.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2012
Same author

Overexpression of neuropilin-1 promotes constitutive MAPK signalling and chemoresistance in pancreatic cancer cells.

British journal of cancer·2005
Same author

The putative therapeutic value of high-dose selenium in proliferative retinopathies may reflect down-regulation of VEGF production by the hypoxic retina.

Medical hypotheses·2004
Same author

Effects of overexpression of ephrin-B2 on tumour growth in human colorectal cancer.

British journal of cancer·2004
Same author

ZD6126 inhibits orthotopic growth and peritoneal carcinomatosis in a mouse model of human gastric cancer.

British journal of cancer·2004
Same author

A shift in myocardial substrate, improved endothelial function, and diminished sympathetic activity may contribute to the anti-anginal impact of very-low-fat diets.

Medical hypotheses·2004
Same journal

Calcitonin Gene-Related Peptide-Induced Central Sensitization: A Hypothesis for Long COVID Symptoms.

Medical hypotheses·2026
Same journal

Subclinical mastitis during lactation: a modifiable risk factor for breast cancer?

Medical hypotheses·2025
Same journal

The Role of Hemispheric Sensory Shifts: Impacts on Stretch Reflex and Motor Plasticity Post-Stroke.

Medical hypotheses·2025
Same journal

Neuron-Targeted Exosome Therapy: A Novel Approach for Treating Cardiogenic Dementia via RyR2 Inhibition.

Medical hypotheses·2025
Same journal

How the Somatosensory System Adapts to the Motor Change in Stroke: A Hemispheric Shift?

Medical hypotheses·2024
Same journal

Unstable Plaque is a Treatable Cause of Cognitive Decline.

Medical hypotheses·2024
See all related articles

Supplemental coenzyme Q10 (CoQ) shows moderate effectiveness in treating hypertension by reducing peripheral resistance. This suggests CoQ may combat vascular superoxide, potentially lowering atherothrombotic risk.

Area of Science:

  • Cardiovascular Research
  • Biochemistry
  • Pharmacology

Background:

  • Hypertension is a major risk factor for cardiovascular disease.
  • Vascular dysfunction, including increased superoxide production, plays a key role in hypertension.
  • Coenzyme Q10 (CoQ) is an essential component of the mitochondrial electron transport chain and an antioxidant.

Purpose of the Study:

  • To evaluate the efficacy of supplemental coenzyme Q10 (CoQ) in treating hypertension.
  • To investigate the mechanism by which CoQ affects blood pressure and vascular function.

Main Methods:

  • Review of reports from multiple research groups.
  • Analysis of two small double-blind clinical studies in humans and animal models.
  • Assessment of changes in total peripheral resistance and vascular superoxide levels.

Related Experiment Videos

Main Results:

  • Supplemental CoQ demonstrated moderate effectiveness in lowering blood pressure in hypertensive humans and animals.
  • CoQ treatment was associated with a decrease in total peripheral resistance.
  • Evidence suggests CoQ acts as an antagonist of vascular superoxide, potentially by reducing cytoplasmic NADH levels.

Conclusions:

  • Coenzyme Q10 (CoQ) is a moderately effective treatment for hypertension.
  • CoQ's mechanism likely involves reducing vascular superoxide production.
  • CoQ therapy may reduce atherothrombotic risk and benefit conditions involving endotheliopathy.